Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham R Foster

Showing results (41-50 of 191) with videos related to

Pageof 20
Sort By:
Pharmacology & Therapeutics|April 10, 2012
Pharmacology and therapeutic potential of interferonsPeter M George, Rekha Badiger, William Alazawi, et al.
Journal of Hepatology|October 27, 2023
Adeno-associated viruses for gene therapy - clinical implications and liver-related complications, a guide for hepatologistsMarcus Maximilian Mücke, Sylvia Fong, Graham R Foster, et al.
Journal of Viral Hepatitis|October 19, 2021
Role of peer support in a hepatitis C elimination programmeDavina Varsha Jugnarain, Rachel Halford, Stuart Smith, et al.
The Journal of Infectious Diseases|October 14, 2009
Cryptosporidium parvum infection rapidly induces a protective innate immune response involving type I interferonFarah M Barakat, Vincent McDonald, Graham R Foster, et al.
Hepatitis Monthly|September 26, 2013
Influencing Factors on the Outcome and Prognosis of Patients With HBV Infction: Seven Years Follow-upShahnaz Sali, Seyed Moayed Alavian, Graham R Foster, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|October 29, 2014
Ethnicity and the diagnosis gap in liver disease: a population-based studyWilliam Alazawi, Rohini Mathur, Kushala Abeysekera, et al.
Nature Reviews. Drug Discovery|December 1, 2007
The way forward in HCV treatment--finding the right pathMichael P Manns, Graham R Foster, Jürgen K Rockstroh, et al.
Journal of Hepatology|July 30, 2022
Viral hepatitis elimination: Towards a hepatitis-free worldMaria Buti, Antonio Craxi, Graham R Foster, et al.
Cellular and Molecular Gastroenterology and Hepatology|November 28, 2020
The A150V Polymorphism of Genotype 3 Hepatitis C Virus Polymerase Inhibits Interferon Alfa by Suppressing Protein Kinase R ActivationWing-Yiu Jason Lee, Meleri Jones, Peter A C Wing, et al.
Scandinavian Journal of Gastroenterology|March 1, 2007
Prediction of sustained virological response in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) and ribavirinGraham R Foster, Michael W Fried, Stephanos J Hadziyannis, et al.
Pageof 20

Showing results (41-50 of 191) with videos related to

Sort By:
Pageof 20
Pharmacology & Therapeutics|April 10, 2012
Pharmacology and therapeutic potential of interferonsPeter M George, Rekha Badiger, William Alazawi, et al.
Journal of Hepatology|October 27, 2023
Adeno-associated viruses for gene therapy - clinical implications and liver-related complications, a guide for hepatologistsMarcus Maximilian Mücke, Sylvia Fong, Graham R Foster, et al.
Journal of Viral Hepatitis|October 19, 2021
Role of peer support in a hepatitis C elimination programmeDavina Varsha Jugnarain, Rachel Halford, Stuart Smith, et al.
The Journal of Infectious Diseases|October 14, 2009
Cryptosporidium parvum infection rapidly induces a protective innate immune response involving type I interferonFarah M Barakat, Vincent McDonald, Graham R Foster, et al.
Hepatitis Monthly|September 26, 2013
Influencing Factors on the Outcome and Prognosis of Patients With HBV Infction: Seven Years Follow-upShahnaz Sali, Seyed Moayed Alavian, Graham R Foster, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|October 29, 2014
Ethnicity and the diagnosis gap in liver disease: a population-based studyWilliam Alazawi, Rohini Mathur, Kushala Abeysekera, et al.
Nature Reviews. Drug Discovery|December 1, 2007
The way forward in HCV treatment--finding the right pathMichael P Manns, Graham R Foster, Jürgen K Rockstroh, et al.
Journal of Hepatology|July 30, 2022
Viral hepatitis elimination: Towards a hepatitis-free worldMaria Buti, Antonio Craxi, Graham R Foster, et al.
Cellular and Molecular Gastroenterology and Hepatology|November 28, 2020
The A150V Polymorphism of Genotype 3 Hepatitis C Virus Polymerase Inhibits Interferon Alfa by Suppressing Protein Kinase R ActivationWing-Yiu Jason Lee, Meleri Jones, Peter A C Wing, et al.
Scandinavian Journal of Gastroenterology|March 1, 2007
Prediction of sustained virological response in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) and ribavirinGraham R Foster, Michael W Fried, Stephanos J Hadziyannis, et al.
Pageof 20